MedTrace Logo

Assessing the Efficacy of Clomiphene Citrate in Patients With Azoospermia and Hypoandrogenism

NCT02137265 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2020-10-05

No results posted yet for this study

Summary

Hypothesis: Prescribed clomiphene citrate to azoospermic patients with hypoandrogenism could improve the sperm retrieval in either fresh sperm or after surgical sperm extraction.

Conditions

  • Non Obstructive Azoospermia
  • Hypogonadism

Interventions

DRUG

Clomiphene

Clomiphene citrate 50 mg orally daily

DRUG

Placebo

One pill every other day

Sponsors & Collaborators

  • University of Illinois at Chicago

    lead OTHER

Principal Investigators

  • Saturnino Luján, MD, PhD · University of Valencia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2020-10-31
Completion
2020-10-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02137265 on ClinicalTrials.gov